Transapical aortic 'valve-in-valve' procedure for degenerated stented bioprosthesis.

Fiche du document

Auteur
Date

2012

Types de document
Périmètre
Langue
Identifiants
Relations

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1093/ejcts/ezr027

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/22011780

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1010-7940

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1873-734X

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_76D477AFF1C16

Licences

info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer



Sujets proches En

Prosthetics Prostheses

Citer ce document

E. Ferrari, « Transapical aortic 'valve-in-valve' procedure for degenerated stented bioprosthesis. », Serveur académique Lausannois, ID : 10.1093/ejcts/ezr027


Métriques


Partage / Export

Résumé 0

Standard surgical aortic valve replacement with a biological prosthesis remains the treatment of choice for low- and mid-risk elderly patients (traditionally >65 years of age) suffering from severe symptomatic aortic valve stenosis or insufficiency, and for young patients with formal contraindications to long-lasting anticoagulation. Unfortunately, despite the fact that several technical improvements have noticeably improved the resistance of pericardial and bovine bioprostheses to leaflet calcifications and ruptures, the risk of early valve failure with rapid degeneration still exists, especially for patients under haemodialysis and for patients

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets

Exporter en